| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | 0.001 | 1 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | 0.0034 | 1 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00071 | 1 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | -0.00072 | 1 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | 0.00092 | 1 |